Beta 2 Glycoprotein 1 IgG and IgM Test

The Beta 2 Glycoprotein 1 IgG and IgM Test is a blood test that measures the levels of IgG and IgM antibodies against beta 2 glycoprotein 1 protein in the blood. Beta 2 glycoprotein 1 is a protein that plays a role in blood clotting and is involved in the development of antiphospholipid syndrome (APS), an autoimmune disorder that increases the risk of blood clots and pregnancy complications.

This test is often ordered when a person has a history of blood clots or has symptoms that suggest APS, such as recurrent miscarriages, deep vein thrombosis (DVT), or pulmonary embolism (PE). It may also be ordered as part of a panel of tests to evaluate unexplained prolonged clotting time, stroke, or heart attack.

The test is simple and requires a blood sample to be drawn from a vein in the arm. It is important to follow any preparation instructions provided by the healthcare provider, such as fasting or avoiding certain medications, to ensure accurate test results.

The Beta 2 Glycoprotein 1 IgG and IgM Test results are reported as positive or negative, indicating the presence or absence of antibodies against beta 2 glycoprotein 1. A positive result suggests that the person may have APS or another autoimmune disorder, but further testing and evaluation are required to confirm the diagnosis. A negative result indicates that the person is unlikely to have APS.